Downloads: 10 | Views: 148 | Weekly Hits: ⮙2 | Monthly Hits: ⮙5

Analysis Study Research Paper | Public Health | India | Volume 13 Issue 10, October 2024 | Popularity: 5.9 / 10

Rate This Article!       View 1 Comments

Analysis of Cost of Treatment Opted for Diabetes and Hypertension During COVID-19

Dr. Naresh Vashist

Abstract: Background: Health sector budget of Himachal Pradesh is ? 3, 139 crore as compare to the union budget ? 89, 155, for the financial year 2023-24 whereas combined expenditure on health sector is 1.18%. India is lagging far behind to reach target of expenditure of health budget. ? 14, 217 crore was spent for COVID-19 emergency response and health system preparedness package and COVID-19 vaccination for healthcare and frontline workers.18% of total outpatient care and 44% of total inpatient care is encompassed in Indian public health sector. In India, 85% of the services are being paid out of the pocket and about 20% of the patients in the OPD nationwide, prefer go to the private hospitals despite higher out of pocket payments.67.0% of the healthcare spending of Indians is on medicine alone whereas 33.0% is for other serves payments. Public expenditure on healthcare in India, stood at 2.1% of GDP in 2021-22 against 1.8% in 2020-21 and 1.3% in 2019-20. High health and medical expenditure has heavy economic burden on government which required a way to restrain its growth. India have highest proportions of household out-of-pocket expenditures on health in the world which is about 71.1%. Inter-state variations, a greater proportion of health expenditure in urban with 29.2% as compare to rural 11.8%. public expenditures allocated to allopathic services. Government is providing the medication for diabetic and hypertension patients free of cost but many of these patients have to purchase the other medicines which are required from the market from their own pocket. This study is regarding the actual expenditure paid and the government price and market price, for the treatment of these diseases during COVID-19 pandemic. Objective: Analysis of cost of treatment opted by the diabetic and hypertension patients during COVID-19. Material and Method: A cross-sectional descriptive study is conducted at various institutional levels and by visiting randomly in different selected areas with help of well-developed questionnaire. The research work is conducted by collecting the data of diabetic and hypertension patients with their cost of treatment during COVID-19 in the years 2020, 2021, 2022 and 2023. Sample size is between 947 participants and total investigations done, are 5498. Results: Total persons investigated are 5498, normal persons are 4551 (82.78%), diseased persons with diabetes, hypertension and diabetes with hypertension are 947 (17.22%), from these diseased 579 are HTN, 213 are DM and 155 are HTN with DM II. Total government price for purchase of allopathic medicines for the calendar years 2020-23 for 947 patients of DM and HTN patients is ?1899125/-, market price is ?17184358/-whereas actual expenditure is ?5889198/-. The government cost for traditional medicines for these patients, is ?268448/-, market price is ?596737/-whereas actual expenditure is ?596737/-. The total actual expenditure is ?6485935/-Conclusion: Healthcare is India?s large sectors. The union budget allocated for financial year 2023-24 is ? 89, 155 crore which is about 13% over ? 79, 145 crores allocated in 2022-23. Total actual expenditure for four years 2020-23, of 947 patients of hypertension, diabetes and hypertension with diabetes, is ? 6485935/-for the purchase of medicines by the patients and in procurement by the government to be provided free of cost to the patients. For the year 2020 it is ?1549428, for the year 2021 it is ?1590778, in year 2022 it is ?1638764 and in year 2023, it is ?1706965. Out of total 5498 persons investigated, normal persons are 4551, whereas diseased persons with diabetes, hypertension and diabetes with hypertension are 947, from these diseased 579 are HTN, 213 are DM and 155 are HTN with DM II. The average cost of treatment for the patients taken for sample is 1405475, 1441757, 1487870, 1554096 and for population of Himachal Pradesh is 64650366, 70012755, 77348815, 84984599, respectively for 2020 to 2023 calendar years.

Keywords: Healthcare budget, GDP, hypertension and diabetes, out-of-pocket expenditure

Edition: Volume 13 Issue 10, October 2024

Pages: 268 - 274

DOI: https://www.doi.org/10.21275/SR241001064034

Make Sure to Disable the Pop-Up Blocker of Web Browser

Click to Cite this Article